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Abstract: Previous studies have reported an association between a more pro-inflammatory 
diet profile and various chronic metabolic diseases. The Dietary Inflammatory Index (DII) 
was used to assess the inflammatory potential of nutrients and foods in the context of a  
dietary pattern. We prospectively examined the association between the DII and the incidence 
of cardiovascular disease (CVD: myocardial infarction, stroke or cardiovascular death) in the 
PREDIMED (Prevención con Dieta Mediterránea) study including 7216 high-risk participants. 
The DII was computed based on a validated 137-item food frequency questionnaire. 
Multivariate-adjusted hazard ratios (HR) and 95% confidence intervals of CVD risk were 
computed across  quartiles of the DII where the lowest (most anti-inflammatory) quartile is  
the referent. Risk increased across the quartiles (i.e., with increasing inflammatory potential): 
HRquartile2 = 1.42 (95%CI = 0.97–2.09);  HRquartile3 = 1.85 (1.27–2.71); and HRquartile4 = 1.73 
(1.15–2.60). When fit as continuous the multiple-adjusted hazard ratio for each additional 
standard deviation of the DII was 1.22 (1.06–1.40). Our results provide direct prospective 
evidence that a pro-inflammatory diet is associated with a higher risk of cardiovascular 
clinical events. 
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1. Introduction 
Cardiovascular diseases (CVD) are the largest cause of morbidity and mortality in the world. It is 
expected that about 25 million people will die due from CVD, especially ischemic heart disease  
and stroke, in 2030 [1]. Atherosclerosis is the main cause of cardiovascular diseases, and inflammation 
is well known to be linked to the development and progression of atherosclerosis [2]. Inflammation is 
involved in all phases of the atherothrombotic process. Not only does promote the onset of the  
vascular injury, but it also leads to the progression and development of atherothrombotic complications 
that are responsible for acute ischemic clinical events [3].  
The relationship between diet and CVDs is well recognized. Diet has been shown to modulate 
inflammation [4,5]. The Western dietary pattern, rich in red meat, refined grains, butter, processed meat, 
high-fat dairy products, sweets and desserts, potatoes, eggs, hydrogenated fats and sugared-sweetened 
beverages, has been associated with increased levels of inflammatory and other intermediate markers of 
CVD [4]. On the other hand, a Mediterranean dietary pattern (rich in olive oil, nuts, fruits and vegetables, 
whole grains and fish, moderate intake of alcohol, but low in red/processed meat, refined grains and sweets) 
has been reported to be associated with lower levels of inflammation and a lower risk of CVD [6–10]. 
Dietary patterns have been studied because they better describe  the eating habits actually followed 
by a population and they take into account possible interactions between nutrients. Food patterns also 
may overcome potential confounding by specific nutrients or foods, and avoid the problem of collinearity 
between foods. However, the large variety of foods available in an average diet results in a large number 
of nutrients that can interact with each other, producing synergistic or antagonistic effects. Overall 
dietary scores allow a better assessment of the dietary pattern. In this context, the Dietary Inflammatory 
Index (DII) was proposed to assess the inflammatory effect of an individual’s diet [11]. The DII 
represents a literature-derived, population-based dietary score summarizing the effect of dietary parameters 
on six inflammatory biomarkers according to a comprehensive review of the published literature. 
In addition to higher levels of inflammatory biomarkers, subjects consuming a pro-inflammatory diet, 
as represented by a higher DII, had increased indices of general and abdominal obesity, as previously 
reported [12]. The purpose of the present study was to prospectively examine the association between 
the DII values and the incidence of CVD during the follow-up interventions in the PREDIMED study.  
2. Materials and Methods 
The PREDIMED study (Prevención con Dieta Mediterránea) is a parallel group, multicenter, randomized 
trial conducted in Spain. The design, methods, and objectives of the PREDIMED study have been 
reported previously [13,14].  
2.1. Participants 
Briefly, participants were men (55 to 80 years of age) and women (60 to 80 years of age) with high 
cardiovascular risk, but with no history of clinical cardiovascular disease at enrollment. They were 
randomly assigned to one of three diets (a Mediterranean diet supplemented with extra-virgin olive oil, 
a Mediterranean diet supplemented with nuts, or a low-fat diet in the control group). Participants received 
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individual and group educational sessions on a quarterly basis-, and, depending on the group assignment, 
free provision of extra-virgin olive oil, mixed nuts, or small nonfood gifts.  
The protocol of the study was approved by the institutional review boards at all study locations. 
The study began on 1 October 2003, and though the follow-up was planned to last for 6 years on 
average, on advice by the Data and Safety Monitoring Board, the trial was stopped early after a median 
follow-up of 4.8 years, on the basis of the results of the fourth interim analysis, which showed early 
evidence of benefit [15].  
2.2. Data Collection and Outcomes 
A 137-item validated food-frequency questionnaire was administered on a yearly basis. Biomarkers 
of compliance were measured in random subsamples of participants at one, three and five years and 
demonstrated adequate compliance with the intended diet in the intervention groups [15,16].  
The primary end point was a composite of myocardial infarction, stroke, and death from cardiovascular 
causes. Secondary end-points were stroke, myocardial infarction, death from cardiovascular causes and 
death from any cause. Contacts with participants, contacts with family physicians, a yearly review of 
medical records, and consultation of the National Death Index were the sources used to identify primary 
and secondary end points. The medical records related to end points were examined by the end-point 
adjudication committee, whose members were unaware of the study-group assignments. Only end points 
that were confirmed by the adjudication committee and had occurred between 1 October 2003, and 1 
December 2010, were included in the analysis.  
The information derived from the 137-item Food-Frequency Questionnaire (FFQ) was used to 
calculate Dietary Inflammatory Index (DII) scores. The procedure used to calculate the DII scores for 
all subjects, from the FFQ, was described elsewhere [11]. Briefly, the DII was derived after a literature 
review from 1950 to 2010, including all articles that had assessed the role of whole foods and dietary 
constituents on interleukins (IL-1B, IL-4, IL-6, IL-10), Tumor Necrosis Factor-alpha and highly 
sensitive C-Reactive Protein (CRP). Overall DII scores for each participant represent the sum of each of 
the DII components in relation to the comparison global diet database. The DII score characterizes an 
individual’s diet on a continuum from maximally anti-inflammatory (negative values, lower quartiles) 
to maximally pro-inflammatory (positive values, higher quartiles) [17].  
2.3. Statistical Analysis 
Participants were categorized into quartiles based on DII scores. Quartile sample size to achieve 
sufficient power was estimated assuming a comparison between extreme quartiles with two-tailed  
alpha error = 0.05, relative risk = 0.60, absolute risk (cumulative incidence) = 4% for two-quartile 
average (3% in the lowest versus 5% in the highest quartile), and statistical power = 0.80. Under  
these assumptions, the required sample size in each of the two extreme quartiles was 1605, which is 
covered with the number of participants in each of our extreme quartiles. Participants with total energy 
intake outside of predefined limits (800 and 4000 Kcal day−1 for men and 500 and 3500 Kcal day−1 for 
women) were excluded (Figure 1). 
Time-to-event data were analyzed using Cox regression models. The time of the event was defined 
as the number of days from recruitment to the last visit, the diagnosis of the clinical cardiovascular event, 
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or death (whichever came first) as determined by the external board of adjudicators of clinical events. 
Cox proportional hazard analyses were conducted with stratification for center and intervention group 
in all models. After a crude analysis, we fitted a model adjusted for sex and age. In a subsequent model 
we additionally adjusted for the major risk factors of cardiovascular disease. Robust standard errors were 
used. All p values were two-tailed. Statistical significance was set at the conventional 0.05 level. 
 
Figure 1. Flow chart of participant selection. 
3. Results 
After exclusions, we included 7216 of the 7447 participants of the PREDIMED trial in our analysis 
(Figure 1). Among them, we observed 277 cardiovascular clinical events during 31,040 persons-years  
of follow-up.  
Table 1 shows the main baseline characteristics of participants according to DII quartiles. The mean 
age of participants was 67.0 (SD: 6.2) years, and 57.4% were women. Participants in the higher quartiles 
of the DII had lower levels of leisure-time physical activity but also lower levels of dyslipidemia at 
baseline. The educational level was higher in participants whose values of the DII were lower, whereas 
their total energy intake was considerably higher. Carbohydrate intake, Polyunsaturated fatty acid 
(PUFA) intake, fiber intake and total intake of alcohol of participants in the lowest quartile of the DII 
were higher than in participants in the highest quartile.  
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Table 1. Description of main characteristics of participants according to the dietary 
inflammatory index score, the PREDIMED (Prevención con Dieta Mediterránea) trial,  
2003–2010. 
Variables  
Quartiles of Dietary Inflammatory Index (DII) (a Higher 
Value Implies Higher Inflammatory Potential) 
 Q1  Q2 Q3 Q4 
DII, median −2.46 −1.34 −0.32 1.17 
Number 1804 1804 1804 1804 
Age, year 66 (6) 67 (6) 67 (6) 68 (6) 
Sex (% Women),  55 57 58 60 
Family history of early CHD, % 23 24 22 20 
Hypertension, % 81 83 84 83 
Dyslipidemia, % 76 72 71 69 
Diabetes, % 48 46 49 52 
Smoking, %     
Never 61 60 62 63 
Former 26 26 24 22 
Current 13 14 14 15 
Body mass index, kg m−2 29.6 (3.9) 30.0 (3.9) 30.0 (3.8) 30.0 (3.8) 
Waist-to-height ratio 0.6 (0.1) 0.6 (0.1) 0.6 (0.1) 0.6 (0.1) 
Physical activity, METS-min day−1 270 (279) 237 (241) 224 (223) 194 (199) 
Marital status, %     
Single 4 5 4 5 
Married 81 75 77 72 
Widowed 13 18 16 19 
Other 2 3 4 3 
Educational level, %     
Primary education or less 74 78 79 80 
Secondary education 17 15 15 14 
College or higher 9 7 6 6 
Total energy intake, kcal day−1 2542 (535) 2347 (512) 2146 (460) 1909 (450) 
Alcohol intake, g day−1 10 (15) 8 (14) 8 (14) 7 (13) 
Protein intake, % energy 16.7 (2.7) 16.5 (2.7) 16.7 (2.8) 16.7 (3.0) 
Carbohydrate intake, % energy 42.5 (7.1) 42.4 (6.9) 41.8 (7.1) 40.5 (7.3) 
Total fat intake, % energy 38 (7) 39 (7) 39 (7) 40 (7) 
Saturated, % energy 9 (2) 10 (2) 10 (2) 11 (2) 
Monounsaturated, % energy 18 (5) 19 (4) 20 (4) 21 (5) 
Polyunsaturated, % energy 7 (2) 6 (2) 6 (2) 6 (2) 
Fiber, g day−1 34 (9) 27 (6) 23 (5) 17 (4) 
Adherence to the Mediterranean diet (0 to 14 points) 10 (2) 9 (2) 8 (2) 8 (2) 
All values are means (standard deviations), unless otherwise stated. When we adjusted for sex and age we did 
observe significant differences (p < 0.001) in age- and sex-adjusted average body mass index (BMI) across 
categories of the Dietary Inflammatory Index (DII). Participants in the highest category of the DII exhibited a 
significantly higher average BMI (30.23, 95% CI: 30.05–30.41) than those in the lowest quartile (BMI = 29.65, 
95% confidence interval (CI): 29.47–29.83) after accounting for differences in sex and age. A similar direct 
and significant age-, and sex-adjusted association was observed for the waist-to-height ratio. 
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Adherence to the Mediterranean diet was inversely associated with the DII, being higher in the lowest 
DII quartile. However, the magnitude of the observed difference in Mediterranean diet adherence 
between extreme DII quartiles was not large. 
Table 2 shows the hazard ratios (95% CI) for the risk of CVD, according to quartiles of the DII 
stratified by center and intervention group. When we adjusted for sex and age, the linear trend tests  
were statistically significant. Linear trend tests remained statistically significant (p < 0.05) after further 
adjustments for additional potential confounders. When we excluded events occurring within the first 
year of follow-up, we observed an even a stronger association with multivariable-adjusted HR above 
1.90 for the two upper quartiles.  
When we assessed the association between the DII and the incidence of CVD using the DII as a 
continuous variable (measured in standard deviation units), we observed that for each additional increase 
of 1 standard deviation in the DII, there was a 22% relative increase in the risk of CVD (95% CI: 6% to 
40%) after multivariable adjustment. 
Results were similar when we repeated the statistical analyses using quintiles instead of quartiles of 
adherence to the DII as the relevant exposure (data not shown, but available on request). There was no 
statistically significant interaction between the intervention arms (Mediterranean diet supplemented with 
either extra-virgin olive oil or Mediterranean diet supplemented with mixed nuts) and the DII. This indicates 
that the association between a more pro-inflammatory diet and a higher risk of CVD was fairly homogeneous 
across the three arms of the trial. 
Figure 2 shows the incidence of cardiovascular disease according to tertiles of the DII. Participants in the 
highest tertile of the DII (the most pro-inflammatory diet) had a significantly higher incidence of the 
composite cardiovascular end-point when compared with the lowest tertile.  
Figure 3 shows the cross-classification according to both intervention groups and the control group 
and to levels of DII dichotomized by the median of DII. The lowest risk of CVD was found in participants 
allocated to an active intervention with the Mediterranean diet and with low baseline values of the DII 
(representing a baseline anti-inflammatory dietary pattern), whereas the highest risk was observed in 
participants with a higher pro-inflammatory diet and allocated to the control group. Intermediate values 
of risk were found for participants in the control group with anti-inflammatory diets at baseline and in 
participants in the active intervention group with pro-inflammatory diets at baseline.  
4. Discussion 
This study provided evidence of a direct prospective association between increased diet-associated 
inflammation, indicated by a higher DII, and a higher risk of cardiovascular disease. The relationship 
showed a strongly linear, dose-response trend. This is consistent with the results reported by  
Ruiz-Canela et al., in this same cohort showing that a higher DII was associated with higher levels of 
general obesity and abdominal obesity, after controlling for the effect that adherence to a MeDiet had on 
inflammation [12]. Three previous reports have shown a positive relationship between a higher DII and 
inflammation [18–20].  
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Table 2. Hazard ratios (95% confidence interval) for the risk of cardiovascular disease, according to the dietary inflammatory index, the 
PREDIMED trial, 2003–2010. 
Hazard Ratios (HR)  
Quartiles of Adherence to the Dietary Inflammatory Index  
Q1 Q2 Q3 Q4 P for trend 
Cases/person-years 49/7641 64/7755 85/7684 79/7960  
Crude HR 1 (ref) 1.32 (0.91–1.92) 1.84 (1.29–2.63) 1.68 (1.16–2.43) 0.003 
Adjusted for age and sex HR 1 (ref) 1.41 (0.96–2.06) 1.87 (1.29–2.69) 1.76 (1.21–2.57) 0.002 
Multivariable adjusted HR 1 1 (ref) 1.42 (0.97–2.09) 1.85 (1.27–2.71) 1.73 (1.15–2.60) 0.008 
After excluding cases with follow-up < 1 year 36/7633 58/7752 73/7678 63/7951  
Crude HR 1 (ref) 1.62 (1.071–2.48) 2.16 (1.43–3.24) 1.83 (1.20–2.78) 0.005 
Adjusted for age and sex HR 1 (ref) 1.75 (1.14–2.68) 2.21 (1.46–3.35) 1.93 (1.26–2.97) 0.004 
Multivariable adjusted HR 1 1 (ref.) 1.76 (1.14–2.70) 2.22 (1.45–3.41) 1.90 (1.20–3.01) 0.012 
1: adjusted for age and sex, overweight/obesity, waist-to-height ratio, total energy intake (quartiles), smoking status (3 categories), diabetes, hypertension, dyslipidemia, 
family history of premature cardiovascular disease, physical activity (quartiles) and educational level, and stratified by intervention group and center. All models were 
stratified by intervention group and center. 
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Figure 2. Incidence of cardiovascular disease according to tertiles of the dietary inflammatory 
index, the PREDIMED trial, 2003–2010. 
 
Figure 3. Cross-classification according to the PREDIMED intervention (both Mediterranean 
diet groups merged together) and to levels of the Dietary Inflammatory Index (DII) 
dichotomized by the median of the DII. Multivariable-adjusted Hazard Ratios for the 
primary end-point (a composite of myocardial infarction, stroke or cardiovascular death). 
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An interesting finding in our study is that we observed a strengthening of the association when we 
excluded events occurring within the first year of follow-up. This is consistent with our initial hypothesis 
because very early events may be related to other previous exposures and not necessarily to the DII measured 
at baseline, i.e., immediately before those events. As it would be unlikely to assume a very short 
induction period for the association between the DII and the occurrence of new CVD clinical events, our 
expectation was to find a stronger association when very early events were removed. 
The association between DII scores, obtained from a food-frequency questionnaire (FFQ), and serum 
levels of inflammatory biomarkers measured in other cohorts have been reported [18–21]. However, we 
did not measure these biomarkers in all participants in our cohort and therefore we were not able to assess 
this association. One advantage of using the DII instead of biomarkers is that we could comment on the direct 
association between dietary exposures and clinical events. Additional advantages include reduced  cost 
and the avoidance of blood collection and analytical determinations. By using a simple, inexpensive, 
noninvasive tool (the FFQ)we were able to assess the role of diet associated inflammation without 
relying on an intermediate measure. .  
Diet has consistently been shown to regulate inflammation [22–25]. Specifically, a modified version 
of the DII has recently been shown to predict a higher summary score for inflammation according to a 
combination of six inflammatory serum biomarkers, and to predict markers of glucose metabolism [26]. 
However, a study from Luxembourg reported no association between the same new, improved DII that 
we used in this study and diastolic blood pressure, CRP, lipids, and glycemic biomarkers [27]. 
In previous analyses of the PREDIMED study, an increased adherence to the Mediterranean diet had 
been shown to be associated with lower levels of CRP. The PREDIMED study also has found lower 
levels of other inflammatory and immune biomarkers associated with better adherence to the  
Mediterranean diet, a higher consumption of some of the typical Mediterranean foods or with the 
interventions conducted in this trial [5,28–31]. The inverse association between the DII and adherence 
to the Mediterranean diet observed in our data is consistent with the predicted association between DII 
and CRP showed by Shivappa et al., in the SEASONS and the Asklepos studies [18,19] and by Wirth et 
al., among police officers [32]. Other studies have reported that higher adherence to the Mediterranean diet 
is associated with decreased levels of inflammatory biomarkers (including CRP, interleukin-6, and 
intracellular adhesion molecule-1) as summarized by a recent meta-analysis [33]. This consistency in 
findings provides further strength to our results. 
Additional strengths of our study are that: (a) we used a prospective follow-up design to ascertain the 
occurrence of clinical events; (b) our analyses were not mainly based in intermediate biomarkers changes 
but provided direct evidence of an association with final hard clinical events; (c) we were able to control 
for a wide array of potentially confounding factors and to assess the combined effect of the baseline 
inflammatory potential of the diet and the dietary intervention. 
Some limitations need also to be acknowledged. Not all foods of the FFQ were included in the 
calculation of the DII. The DII was built using articles that examined the effect of individual nutrients 
in relation to intermediate biomarkers, but it did not assess the effect of the overall dietary pattern intake 
on these biomarkers. As the DII was created depending on the published literature, there could be findings 
that were not included or not published because of null findings (i.e., publication bias may have occurred). 
In any case, the DII was created based on an extensive literature search and did not take into account 
only certain nutrients or foods but tried to assess many of them, and, therefore, in this way did assess the 
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whole diet. Also, there were a large number of null results reported in the reviewed  literature. Other 
limitations are related to the generalizability of our findings. Because all study participants lived in a 
Mediterranean country and were at high cardiovascular risk, extrapolating our results requires replication 
in other settings and populations. In any case, the fact is that participants in the PREDIMED study, 
despite being high-risk subjects, had an average lower DII (−0.75, SD: 1.53) than participants in previous 
studies that have assessed the inflammatory capacity of the diet using the DII (+0.84 SD: 1.99) [19]. 
5. Conclusions 
In summary, we found for the first time prospective direct evidence that diets with higher  
pro-inflammatory potential were directly associated with a increased likelihood of developing clinical 
cardiovascular events. This direct association was strong, gradual, and consistent across different methods 
of categorizing the dietary inflammatory capacity and showed a  linear dose-response trend. 
Acknowledgments 
This research was supported by the official funding agency for biomedical research of the Spanish 
government, Instituto de Salud Carlos III (ISCIII), through grants provided to research networks 
specifically developed for the trial (RTIC G03/140, to RE; RTIC RD 06/0045, to MAM-G) and through 
Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBERobn), 
and by grants from Centro Nacional de Investigaciones Cardiovasculares (CNIC 06/2007), the Fondo de 
Investigación Sanitaria–Fondo Europeo de Desarrollo Regional (Proyecto de Investigación (PI) 04-2239, PI 
05/2584, CP06/00100, PI07/0240, PI07/1138, PI07/0954, PI 07/0473, PI10/01407, PI10/02658, 
PI11/01647, P11/02505 and PI13/00462), the Ministerio de Ciencia e Innovación (Recursos y 
teconologia agroalimentarias (AGL)-2009-13906-C02 and AGL2010-22319-C03 and AGL2013-49083-
C3-1-R), the Fundación Mapfre 2010, the Consejería de Salud de la Junta de Andalucía (PI0105/2007), 
the Public Health Division of the Department of Health of the Autonomous Government of Catalonia, 
the Generalitat Valenciana (Generalitat Valenciana Ayuda Complementatia (GVACOMP) 06109, 
GVACOMP2010-181, GVACOMP2011-151), Conselleria de Sanitat y AP; Atención Primaria (CS) 
2010-AP-111, and CS2011-AP-042), Regional Government of Navarra (P27/2011), and Centre Català 
de la Nutrició de l'Institut d'Estudis Catalans. ET is supported by a Rio Hortega post-residency fellow of 
the Instituto de Salud Carlos III, Ministry of Economy and Competitiveness, Spanish Government. 
ROLE OF THE FUNDERS: funding sources had no role in the designing and conducting of the study; 
collection, management, analysis, and interpretation of the data; and preparation, review, or approval of 
the manuscript. 
Author Contributions 
M.A.M.-G. & M.R.-C. conceived the study. A.G.-A., & M.A.M.-G. conducted the statistical analyses. 
A.G.-A. & R.R. wrote the first draft of the manuscript. M.A.M.-G., J.S.-S., M.Fito, E.R., D.C., E.G.-G., 
R.E., J.L., F.A., M.Fiol, L. S.-M., X.P. and J.A.M provided funding and administrative support. M.A.M.-G., 
A.G.-A., J.S.-S., M.Fito, D.C., E.G.-G., R.E., J.L., F.A., M.Fiol, L. S.-M., X.P. recruited the participants. 
All authors contributed to the manuscript with important intellectual content and approved its final version.  
Nutrients 2015, 7 4135 
 
 
The following investigators contributed with the recruitment of participants; University of Navarra 
and Osasunbidea (Servicio Navarro de Salud), Primary Care Centres, Pamplona, Spain: P. Buil-Cosiales, 
J. Diez-Espino, E Toledo, B. Sanjulian, A. Marti, F.J. Basterra-Gortari, V. Estremera-Urabayen,  
A. Sola-Larraza, F. Barcena-Amigo, C. Oreja-Arrayago, M. Serrano-Martínez, M.J. Lasanta-Saez,  
L. Quintana-Pedraza, C. Amezcueta-Goñi, P. Cia-Lecumberri, F. Artal-Moneva, J.M. Esparza-López, 
E. Figuerido-Garmendia, H. Ruiz-Millan, R. Oses-Primo, J.A. Tabar-Sarrias, L. Fernandez-Urzainqui, 
M.J. Ariz-Arnedo, T. Forcen-Alonso, P. Pascual-Pascual, M.L. Garces, V. Extremera, L. Garcia-Perez. 
University Rovira i Virgili, Reus, Spain: J. Basora, N. Gonzalez, C. Molina, F. Marquez, P. Martínez,  
N. Ibarrola, M. Sorli, J. García Roselló, A. Castro, F. Martin, N. Tort, A. Isach, M. Guasch-Ferre,  
M. Baldrich, J.J. Cabre, G. Mestres, F. Paris, M. Llauradó, R. Pedret, J. Basells, J. Vizcaino, and  
J. Fernandez-Ballart.  
University of Valencia, Valencia, Spain: P. Carrasco, R. Osma, M. Guillen, P. Guillem-Saiz,  
O. Portoles, V. Pascual, C. Riera, J. Valderrama, A. Serrano, E. Lazaro, A. Sanmartin, A. Girbes,  
V. Santamaria, C. Sanchez, Z. Pla, and E.  
Institute de Recerca Hospital del Mar, Barcelona, Spain: M.I. Covas, S. Tello, J. Vila, R. de la Torre,  
D. Munoz-Aguayo, R. Elosua, J. Marrugat, and M. Ferrer. 
University Hospital of Alava, Vitoria, Spain: F. Arós, I. Salaverria, T. del Hierro, J. Algorta,  
S. Francisco, A. Alonso-Gómez, E. Sanz, J. Rekondo, M.C. Belló and A. Loma-Osorio. 
University of Malaga, Malaga, Spain: J Fernandez-Crehuet, J. Wärnberg, R. Benitez Pont, M. Bianchi 
Alba, R. Gomez-Huelgas, J. Martínez-Gonzalez, V. Velasco García, J. de Diego Salas, A. Baca Osorio, 
J. Gil Zarzosa, J.J. Sanchez Luque, and E. Vargas López. 
Hospital Clinic, Institut d’Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain:  
M. Serra, A. Perez-Heras, R. Sola, E. Ortega, C. Vinas, R. Casas, L. de Santamaria, S. Romero,  
J.M. Baena, M. García, M. Oller, J. Amat, I. Duaso, Y. García, C. Iglesias, C. Simon, Ll. Quinzavos,  
Ll. Parra, M. Liroz, J. Benavent, J. Clos, I. Pla, M. Amoros, M.T. Bonet, M.T. Martin, M.S. Sanchez,  
J. Altirruba, E. Manzano, A. Altes, M. Cofan, C. Valls-Pedret, A. Sala-Vila, and M. Domenech. 
Institute of Health Sciences IUNICS, University of Balearic Islands, and Hospital Son Espases, Palma 
de Mallorca, Spain: M. García -Valdueza, M. Monino, A. Proenza, R. Prieto, G. Frontera, M. Ginard,  
F. Fiol, A. Jover, D. Romaguera and J. García. 
Department of Family Medicine, Distrito Sanitario de Atención Primaria Sevilla, Spain:  
J.M. Santos-Lozano, M. Leal, E. Martínez, M. Ortega-Calvo, P. Roman, F. Jose García, P. Iglesias,  
Y. Corchado, E. Mayoral, L. Mellado, L. Miró, JM. Lozano and C. Lama. 
School of Pharmacy, University of Barcelona, Barcelona, Spain: M.C. López- Sabater,  
A.I. Castellote-Bargallo, A. Medina-Remon, and A. Tresserra-Rimbau. 
University of Las Palmas de Gran Canaria, Las Palmas, Spain: J. Alvarez-Perez, E. Diez Benitez,  
I. Bautista Castaño, I. Maldonado Diaz, A. Sanchez-Villegas, M.J. Férnandez-Rodríguez, F. Sarmiendo 
de la Fe, C. Simon García, I. Falcon Sanabria, B. Macias Gutierrez, and A.J. Santana Santana. 
Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain: E. de la Cruz,  
A. Galera, Y. Soler, F. Trias, I. Sarasa, E. Padres, and E. Corbella. 
Primary Care Division, Catalan Institute of Health, Barcelona, Spain: C. Cabezas, E. Vinyoles,  
M.A. Rovira, L. García, G. Flores, J.M. Verdu, P. Baby, A. Ramos, L. Mengual, P. Roura, M.C. Yuste, 
A. Guarner, A. Rovira, M.I. Santamaria, M. Mata, C. de Juan, and A. Brau. 
Nutrients 2015, 7 4136 
 
 
Other investigators of the PREDIMED network: J.A. Tur (University of Balearic Islands),  
M.P. Portillo (University of Basque Country) and G. Saez (University of Valencia) 
Conflicts of Interest 
The authors declare no conflict of interest. 
Declaration 
James R. Hébert owns controlling interest in Connecting Health Innovations LLC (CHI), a company 
planning to license the right to his invention of the dietary inflammatory index (DII) from the University 
of South Carolina in order to develop computer and smart phone applications for patient counseling and 
dietary intervention in clinical settings. Nitin Shivappa is an employee of CHI. The subject matter of this 
paper will have no direct bearing on the work of CHI, nor has any CHI-related activity exerted any influence 
on this project. Other authors declare no conflict of interest. 
References 
1. World Health Organization. World Health Statistics; World Health Organization: Geneva, 
Switzertland, 2012. 
2. Ross, R. Atherosclerosis—An inflammatory disease. N. Engl. J. Med. 1999, 340, 115–126. 
3. Páramo, J.; Rodríguez, J.; Orbe, J. Atherosclerosis in inflammatory diseases. Med. Clin. 2007, 128, 
749–756. 
4. Lopez-Garcia, E.; Schulze, M.B.; Fung, T.T.; Meigs, J.B.; Rifai, N.; Manson, J.E.; Hu, F.B.; 
Schulze, M. Major dietary patterns are related to plasma concentrations of markers of inflammation 
and endothelial dysfunction. Am. J. Clin. Nutr. 2004, 80, 1029–1035. 
5. Salas-Salvadó, J.; Garcia-Arellano, A.; Estruch, R.; Marquez-Sandoval, F.; Corella, D.; Fiol, M.; 
Gómez-Gracia, E.; Viñoles, E.; Arós, F.; Herrera, C.; et al. Components of the Mediterranean-type 
food pattern and serum inflammatory markers among patients at high risk for cardiovascular disease. 
Eur. J. Clin. Nutr. 2008, 62, 651–659.  
6. Esmaillzadeh, A.; Kimiagar, M.; Mehrabi, Y.; Azadbakht, L.; Hu, F.B.; Willett, W.C. Dietary patterns 
and markers of systemic inflammation among Iranian women. J. Nutr. 2007, 137, 992–998. 
7. Fung, T.; Rexrode, K.M.; Mantzoros, C.S.; Manson, J.E.; Willett, W.C.; Hu, F.B. Mediterranean 
diet and incidence of and mortality from coronary heart disease and stroke in women. Circulation 
2009, 119, 1093–1100.  
8. Martínez-González, M.; García-López, M.; Bes-Rastrollo, M.; Toledo, E.; Martínez-Lapiscina, E.H.; 
Delgado-Rodriguez, M.; Vazquez, Z.; Benito, S.; Beunza, J.J. Mediterranean diet and the incidence 
of cardiovascular disease: A Spanish cohort. Nutr. Metab. Cardiovasc. Dis. 2011, 21, 237–244. 
9. Trichopoulou, A.; Martínez-González, M.A.; Tong, T.Y.; Forouhi, N.G.; Khandelwal, S.; 
Prabhakaran, D.; Mozaffarian, D.; de Lorgeril, M. Definitions and potential health benefits of the 
Mediterranean diet: Views from experts around the world. BMC Med. 2014, 12, 112. 
10. Martinez-Gonzalez, M.A.; Bes-Rastrollo, M. Dietary patterns, Mediterranean diet, and cardiovascular 
disease. Curr. Opin. Lipidol. 2014, 25, 20–26. 
Nutrients 2015, 7 4137 
 
 
11. Shivappa, N.; Steck, S.E.; Hurley, T.G.; Hussey, J.R.; Hébert, J.R. Designing and developing a 
literature-derived, population-based dietary inflammatory index. Public Health Nutr. 2014, 17, 
1689–1696.  
12. Ruiz-Canela, M.; Zazpe, I.; Shivappa, N.; Hébert, J.R.; Sánchez-Tainta, A.; Corella, D.;  
Salas-Salvadó, J.; Fitó, M.; Lamuela-Raventós, R.M.; Fernández-Crehuet, J.; et al. Dietary 
inflammatory index and anthropometric measures of obesity in a population sample at high 
cardiovascular risk from the PREDIMED trial. Br. J. Nutr. 2015, 13, 984–995. 
13. Martínez-González, M.; Corella, D.; Salas-Salvadó, J.; Ros, E.; Covas, M.I.; Fiol, M.; Wärnberg, J.; 
Arós, F.; Ruíz-Gutiérrez, V.; Lamuela-Raventós, R.M.; et al. Cohort profile: Design and methods 
of the PREDIMED study. Int. J. Epidemiol. 2012, 41, 377–385.  
14. Ros, E.; Martínez-González, M.A.; Estruch, R.; Salas-Salvadó, J.; Fitó, M.; Martínez, J.A.; Corella, D. 
Mediterranean diet and cardiovascular health: Teachings of the PREDIMED study. Adv. Nutr. 2014, 
5, 330S–336S. 
15. Estruch, R.; Ros, E.; Salas-Salvadó, J.; Covas, M.I.; Corella, D.; Arós, F.; Gómez-Gracia, E.;  
Ruiz-Gutiérrez, V.; Fiol, M.; Lapetra, J.; et al. Primary prevention of cardiovascular disease with a 
Mediterranean diet. N. Engl. J. Med. 2013, 368, 1279–1290. 
16. Zazpe, I.; Sanchez-Tainta, A.; Estruch, R.; Lamuela-Raventos, R.M.; Schröder, H.; Salas-Salvado, J.; 
Corella, D.; Fiol, M.; Gomez-Gracia, E.; Aros, F.; et al. A large randomized individual and group 
intervention conducted by registered dietitians increased adherence to Mediterranean-type diets: 
The Predimed study. J. Am. Diet. Assoc. 2008, 108, 1134–1144. 
17. Tabung, F.; Steck, S.E.; Ma, Y.; Liese, A.D., Zhang, J.; Caan, B.; Hou, L.; Johnson, K.C.; 
Mossavar-Rahmani, Y.; Shivappa, N.; et al. The association between dietary inflammatory index 
and risk of colorectal cancer among postmenopausal women: Results from the Women’s Health 
Initiative. Cancer Causes Control 2015, 26, 399–408. 
18. Shivappa, N.; Hébert, J.R.; Rietzschel, E.R.; de Buyzere, M.L.; Langlois, M.; Debruyne, E.; 
Marcos, A.; Huybrechts, I. Associations between dietary inflammatory index and inflammatory 
markers in the Asklepios Study. Br. J. Nutr. 2015, 113, 665–671.  
19. Shivappa, N.; Steck, S.E.; Hurley, T.G.; Hussey, J.R.; Ma, Y.; Ockene, I.S.; Tabung, F.; Hébert, J.R.  
A population-based dietary inflammatory index predicts levels of C-reactive protein in the Seasonal 
Variation of Blood Cholesterol Study (SEASONS). Public Health Nutr. 2014, 17, 1825–1833. 
20. Wood, L.G.; Shivappa, N.; Berthon, B.S.; Gibson, P.G.; Hebert, J.R. Dietary inflammatory index is 
related to asthma risk, lung function and systemic inflammation in asthma. Clin. Exp. Allergy 2015, 
45, 177–183. 
21. Tabung, F.K.; Steck, S.E.; Zhang, J.; Ma, Y.; Liese, A.D.; Agalliu, I.; Hingle, M.; Hou, L.;  
Hurley, T.G.; Jiao, L.; et al. Construct validation of the dietary inflammatory index among 
postmenopausal women. Ann. Epidemiol. 2015, 25, 398–405. 
22. Khan, N.; Khymenets, O.; Urpí-Sardà, M.; Tulipani, S.; Garcia-Aloy, M.; Monagas, M.;  
Mora-Cubillos, X.; Llorach, R.; Andres-Lacueva, C. Cocoa polyphenols and inflammatory markers 
of cardiovascular disease. Nutrients 2014, 6, 844–880. 
23. Wang, Y.; Chun, O.K.; Song, W.O. Plasma and dietary antioxidant status as cardiovascular disease 
risk factors: A review of human studies. Nutrients 2013, 5, 2969–3004. 
Nutrients 2015, 7 4138 
 
 
24. Gariballa, S.; Kosanovic, M.; Yasin, J.; El Essa, A. Oxidative damage and inflammation in obese 
diabetic Emirati subjects. Nutrients 2014, 6, 4872–4880. 
25. Hermsdorff, H.H.; Zulet, M.Á.; Abete, I.; Martínez, J.A. A legume-based hypocaloric diet reduces 
proinflammatory status and improves metabolic features in overweight/obese subjects. Eur. J. Nutr. 
2011, 50, 61–69.  
26. Van Woudenbergh, G.; Theofylaktopoulou, D.; Kuijsten, A.; Ferreira, I.; van Greevenbroek, M.M.; 
van der Kallen, C.J.; Schalkwijk, C.G.; Stehouwer, C.D.; Ocké, M.C.; Nijpels, G.; et al. Adapted 
dietary inflammatory index and its association with a summary score for low-grade inflammation 
and markers of glucose metabolism: The Cohort study on Diabetes and Atherosclerosis Maastricht 
(CODAM) and the Hoorn study. Am. J. Clin. Nutr. 2013, 98, 1533–1542. 
27. Alkerwi, A.; Shivappa, N.; Crichton, G.; Hébert, J.R. No significant independent relationships with 
cardiometabolic biomarkers were detected in the Observation of Cardiovascular Risk Factors in 
Luxembourg study population. Nutr. Res. 2014, 34, 1058–1065.  
28. Casas, R.; Sacanella, E.; Urpí-Sardà, M.; Chiva-Blanch, G.; Ros, E.; Martínez-González, M.A.; 
Covas, M.I.; Lamuela-Raventos, R.M.; Salas-Salvadó, J.; Fiol, M.; et al. The effects of the 
mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects 
with high risk for cardiovascular disease. A randomized trial. PLoS ONE 2014, 9, e100084. 
29. Bulló, M.; Casas, R.; Portillo, M.P.; Basora, J.; Estruch, R.; García-Arellano, A.; Lasa, A.;  
Juanola-Falgarona, M.; Arós, F.; Salas-Salvadó, J. Dietary glycemic index/load and peripheral 
adipokines and inflammatory markers in elderly subjects at high cardiovascular risk. Nutr. Metab. 
Cardiovasc. Dis. 2013, 23, 443–450. 
30. Estruch, R.; Martínez-González, M.A.; Corella, D.; Salas-Salvadó, J.; Ruiz-Gutiérrez, V.;  
Covas, M.I.; Fiol, M.; Gómez-Gracia, E.; López-Sabater, M.C.; Vinyoles, E.; et al. Effects of a 
Mediterranean-style diet on cardiovascular risk factors: A randomized trial. Ann. Intern. Med. 2006, 
145, 1–11. 
31. Mena, M.; Sacanella, E.; Vazquez-Agell, M.; Morales, M.; Fitó, M.; Escoda, R.; Serrano-Martínez, M.; 
Salas-Salvadó, J.; Benages, N.; Casas, R.; et al. Inhibition of circulating immune cell activation:  
A molecular antiinflammatory effect of the Mediterranean diet. Am. J. Clin. Nutr. 2009, 89, 248–256. 
32. Wirth, M.; Burch, J.; Shivappa, N.; Violanti, J.M.; Burchfiel, C.M.; Fekedulegn, D.; Andrew, M.E.; 
Hartley, T.A.; Miller, D.B.; Mnatsakanova, A.; et al. Association of a dietary inflammatory index 
with inflammatory indices and metabolic syndrome among police officers. J. Occup. Environ. Med. 
2014, 56, 986–989. 
33. Schwingshackl, L.; Hoffmann, G. Mediterranean dietary pattern, inflammation and endothelial 
function: A systematic review and meta-analysis of intervention trials. Nutr. Metab. Cardiovasc. Dis. 
2014, 24, 929–939. 
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/4.0/). 
